Inhibition of keloid by 32P isotope radiotherapy through suppressing TGF-β/Smad signaling pathway
Aging · 2023
DOI: 10.18632/aging.205160 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging, 2023. Verfasst von Long Xie und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, China. Hauptthemen laut MEDLINE: Keloid. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nuclear Medicine, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, China.
Zitieren
APA
Xie, L., Huang, L., Zhang, G., & Su, Y. (2023). Inhibition of keloid by 32P isotope radiotherapy through suppressing TGF-β/Smad signaling pathway. Aging. https://doi.org/10.18632/aging.205160
Vancouver
Xie L, Huang L, Zhang G, Su Y. Inhibition of keloid by 32P isotope radiotherapy through suppressing TGF-β/Smad signaling pathway. Aging. 2023. doi:10.18632/aging.205160
BibTeX
@article{Xie2023,
author = {Xie, Long and Huang, Liqun and Zhang, Guanjie and Su, Yingrui},
title = {Inhibition of keloid by 32P isotope radiotherapy through suppressing TGF-β/Smad signaling pathway},
journal = {Aging},
year = {2023},
doi = {10.18632/aging.205160}
}
EUVIMED